{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:39:47Z","timestamp":1783420787965,"version":"3.54.6"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lung cancer is a malignant tumour with the fastest increase in morbidity and mortality around the world. The clinical treatments available have significant side effects, thus it is desirable to identify alternative modalities to treat lung cancer. Shashen Maidong decoction (SMD) is a commonly used traditional Chinese medicine (TCM) formula for treating lung cancer in the clinic. While the key functional components (KFC) and the underlying mechanisms of SMD treating lung cancer are still unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We propose a new integrated pharmacology model, which combines a novel node-importance calculation method and the contribution decision rate (CDR) model, to identify the KFC of SMD and to deduce their mechanisms in the treatment of lung cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The enriched effective Gene Ontology (GO) terms selected from our proposed node importance detection method could cover 97.66% of enriched GO terms of reference targets. After calculating CDR of active components in key functional network, the first 82 components covered 90.25% of the network information, which were defined as KFC. 82 KFC were subjected to functional analysis and experimental validation. 5\u201340\u00a0\u03bcM protocatechuic acid, 100\u2013400\u00a0\u03bcM paeonol or caffeic acid exerted significant inhibitory activity on the proliferation of A549 cells. The results show that KFC play an important therapeutic role in the treatment of lung cancer by targeting Ras, AKT, IKK, Raf1, MEK, and NF-\u03baB in the PI3K-Akt, MAPK, SCLC, and NSCLC signaling pathways active in lung cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides a methodological reference for the optimization and secondary development of TCM formulas. The strategy proposed in this study can be used to identify key compounds in the complex network and provides an operable test range for subsequent experimental verification, which greatly reduces the experimental workload.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12906-023-03985-y","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:36:13Z","timestamp":1684161373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jieqi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daogang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"6","key":"3985_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"3985_CR2","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1158\/1078-0432.CCR-15-1915","volume":"22","author":"S Ortiz-Cuaran","year":"2016","unstructured":"Ortiz-Cuaran S, Scheffler M, Plenker D, et al. Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors. Clin Cancer Res. 2016;22(19):4837\u201347.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"3985_CR3","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1002\/ijc.32025","volume":"144","author":"YT Lin","year":"2019","unstructured":"Lin YT, Chen JS, Liao WY, et al. Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations. Int J Cancer. 2019;144(11):2887\u201396.","journal-title":"Int J Cancer"},{"issue":"6","key":"3985_CR4","first-page":"563","volume":"13","author":"G Cheng","year":"2010","unstructured":"Cheng G, Zhang L. Adverse events related to bevacizumab and the management principles in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2010;13(6):563\u20137.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"4","key":"3985_CR5","first-page":"274","volume":"23","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ni Y, Li L, Xin T. Acquired drug resistance mechanism of osimertinib in the targeted therapy of non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2020;23(4):274\u201381.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"24","key":"3985_CR6","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1097\/CM9.0000000000001141","volume":"133","author":"XL Su","year":"2020","unstructured":"Su XL, Wang JW, Che H, et al. Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chin Med J (Engl). 2020;133(24):2987\u201397.","journal-title":"Chin Med J (Engl)"},{"key":"3985_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fphar.2020.00798","volume":"11","author":"B Zhao","year":"2020","unstructured":"Zhao B, Hui X, Jiao L, et al. A TCM formula YYWY inhibits tumor growth in non-small cell lung cancer and enhances immune-response through facilitating the maturation of dendritic cells. Front Pharmacol. 2020;11:798.","journal-title":"Front Pharmacol"},{"issue":"28","key":"3985_CR8","doi-asserted-by":"publisher","first-page":"e25002","DOI":"10.1097\/MD.0000000000025002","volume":"100","author":"X Zheng","year":"2021","unstructured":"Zheng X, Wang W, Wang G, Liu S. Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial. Medicine (Baltimore). 2021;100(28):e25002.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"3985_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00432-011-0975-3","volume":"137","author":"ZY Xu","year":"2011","unstructured":"Xu ZY, Jin CJ, Zhou CC, et al. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. J Cancer Res Clin Oncol. 2011;137(7):1117\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3985_CR10","first-page":"6752","volume":"13","author":"M He","year":"2021","unstructured":"He M, Luo Y, Chen L, et al. Shashen maidong decoction: the effect of TNF-alpha and IL-6 on lung cancer cachexia based on cancer toxicity theory. Am J Transl Res. 2021;13(6):6752\u20138.","journal-title":"Am J Transl Res"},{"issue":"12","key":"3985_CR11","first-page":"87","volume":"5","author":"QH Huang","year":"2021","unstructured":"Huang QH, Liang YJ, Chen N, Du XT. Effect of Shashen Maidong decoction on tumor marker levels in patients with non-small cell lung cancer. Mod Med Health Res Electron J. 2021;5(12):87\u20139.","journal-title":"Mod Med Health Res Electron J"},{"issue":"08","key":"3985_CR12","first-page":"62","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang SY, Pan YN, et al. lnfluences of Shashen Maidong decoction-containing serum combined with cisplatin on expressions of E-cadherin and snail in lung adenocarcinoma A549 cells. Chin Arch Tradit Chin Med. 2021;39(08):62\u20135.","journal-title":"Chin Arch Tradit Chin Med"},{"issue":"05","key":"3985_CR13","first-page":"144","volume":"47","author":"WW Xu","year":"2020","unstructured":"Xu WW, Liu CY. Effect of Shashen Maidong decoction combined with cisplatin on proliferation of lung cancer cell line A549 and expressions of Smad7 and TGF-\u03b21 protein. Liaoning J Tradit Chin Med. 2020;47(05):144\u20137.","journal-title":"Liaoning J Tradit Chin Med"},{"key":"3985_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biopha.2016.12.093","volume":"87","author":"J Chen","year":"2017","unstructured":"Chen J, Yuan J, Zhou L, et al. Regulation of different components from ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K\/Akt\/mTOR signaling pathway. Biomed Pharmacother. 2017;87:118\u201326.","journal-title":"Biomed Pharmacother"},{"key":"3985_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijbiomac.2017.08.033","volume":"106","author":"J Wu","year":"2018","unstructured":"Wu J, Gao W, Song Z, et al. Anticancer activity of polysaccharide from Glehnia littoralis on human lung cancer cell line A549. Int J Biol Macromol. 2018;106:464\u201372.","journal-title":"Int J Biol Macromol"},{"issue":"03","key":"3985_CR16","first-page":"328","volume":"30","author":"S Li","year":"2015","unstructured":"Li S, Zhou X, Xiong H. Clinical study of Shashenmaidong decoction in the treatment of clinical study of Shashenmaidong decoction in the treatment of clinical study of Shashenmaidong decoction in the treatment of clinical study of Shashenmaidong decoction in the treatment of radiation pneumonitis. Acta Chin Med. 2015;30(03):328\u20139.","journal-title":"Acta Chin Med"},{"issue":"11","key":"3985_CR17","first-page":"53","volume":"13","author":"M Liu","year":"2020","unstructured":"Liu M, Wu YL, Zeng R. Observation on the effect of Jiajian Shashen Maidong decoction combined with chemotherapy in the treatment of non-small cell lung cancer. Chin J Clin Rational Drug Use. 2020;13(11):53\u20134.","journal-title":"Chin J Clin Rational Drug Use"},{"key":"3985_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fphar.2020.01035","volume":"11","author":"KX Wang","year":"2020","unstructured":"Wang KX, Gao Y, Lu C, et al. Uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network pharmacology model. Front Pharmacol. 2020;11:1035.","journal-title":"Front Pharmacol"},{"key":"3985_CR19","doi-asserted-by":"crossref","first-page":"6641838","DOI":"10.1155\/2021\/6641838","volume":"2021","author":"L Yang","year":"2021","unstructured":"Yang L, Fan L, Wang K, et al. Analysis of molecular mechanism of erxian decoction in treating osteoporosis based on formula optimization model. Oxid Med Cell Longev. 2021;2021:6641838.","journal-title":"Oxid Med Cell Longev"},{"issue":"D1","key":"3985_CR20","first-page":"D845","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1):D845\u201355.","journal-title":"Nucleic Acids Res"},{"key":"3985_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"issue":"D1","key":"3985_CR22","doi-asserted-by":"publisher","first-page":"D976","DOI":"10.1093\/nar\/gky987","volume":"47","author":"HY Xu","year":"2019","unstructured":"Xu HY, Zhang YQ, Liu ZM, et al. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2019;47(D1):D976\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3985_CR23","doi-asserted-by":"publisher","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","volume":"47","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang F, Yang K, et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 2019;47(D1):D1110\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3985_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33.","journal-title":"J Cheminform"},{"key":"3985_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet LZ, Hosey CM, Ursu O, Oprea TI. BDDCS, the rule of 5 and drugability. Adv Drug Deliv Rev. 2016;101:89\u201398.","journal-title":"Adv Drug Deliv Rev"},{"key":"3985_CR26","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.","journal-title":"Sci Rep"},{"issue":"Web Server issu","key":"3985_CR27","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42(Web Server issue):W32\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"3985_CR28","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/bioinformatics\/btt303","volume":"29","author":"X Liu","year":"2013","unstructured":"Liu X, Vogt I, Haque T, Campillos M. HitPick: a web server for hit identification and target prediction of chemical screenings. Bioinformatics. 2013;29(15):1910\u20132.","journal-title":"Bioinformatics"},{"issue":"2","key":"3985_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25(2):197\u2013206.","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"3985_CR30","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3985_CR31","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"5","key":"3985_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"3985_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3985_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"issue":"D1","key":"3985_CR35","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"3985_CR36","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016.","DOI":"10.1007\/978-3-319-24277-4"},{"key":"3985_CR37","doi-asserted-by":"publisher","unstructured":"Lv J, Zhu S, Chen H, et al. Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR-126-5p\/ZEB2 axis. Drug Dev Res. 2022;83(2):432\u201346. https:\/\/doi.org\/10.1002\/ddr.21873.","DOI":"10.1002\/ddr.21873"},{"key":"3985_CR38","doi-asserted-by":"publisher","first-page":"572616","DOI":"10.3389\/fphar.2020.572616","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Chen WX, Li LL, et al. Paeonol suppresses proliferation and motility of non-small-cell lung cancer cells by disrupting STAT3\/NF-kappaB signaling. Front Pharmacol. 2020;11:572616.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3985_CR39","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.3390\/ijms13056236","volume":"13","author":"CL Lin","year":"2012","unstructured":"Lin CL, Chen RF, Chen JY, et al. Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-kappaB pathway. Int J Mol Sci. 2012;13(5):6236\u201345.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"3985_CR40","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1021\/jf9004466","volume":"57","author":"MC Yin","year":"2009","unstructured":"Yin MC, Lin CC, Wu HC, Tsao SM, Hsu CK. Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J Agric Food Chem. 2009;57(14):6468\u201373.","journal-title":"J Agric Food Chem"},{"key":"3985_CR41","unstructured":"Sun Y. Chemical composition analysis and pharmacokinetic study of the Shasheng Maidong decoction. PhD thesis. Hebei Medical University; 2016."},{"issue":"9","key":"3985_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/nu8090529","volume":"8","author":"F Khan","year":"2016","unstructured":"Khan F, Niaz K, Maqbool F, et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 2016;8(9):529.","journal-title":"Nutrients"},{"issue":"1","key":"3985_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/etm.2017.4494","volume":"14","author":"F Wu","year":"2017","unstructured":"Wu F, Chen J, Fan LM, et al. Analysis of the effect of rutin on GSK-3beta and TNF-alpha expression in lung cancer. Exp Ther Med. 2017;14(1):127\u201330.","journal-title":"Exp Ther Med"},{"issue":"3","key":"3985_CR44","first-page":"997","volume":"24","author":"Q Tian","year":"2019","unstructured":"Tian Q, Wang L, Sun X, Zeng F, Pan Q, Xue M. Scopoletin exerts anticancer effects on human cervical cancer cell lines by triggering apoptosis, cell cycle arrest, inhibition of cell invasion and PI3K\/AKT signalling pathway. J BUON. 2019;24(3):997\u20131002.","journal-title":"J BUON"},{"issue":"10","key":"3985_CR45","doi-asserted-by":"publisher","first-page":"e22382","DOI":"10.1002\/jbt.22382","volume":"33","author":"SK Velli","year":"2019","unstructured":"Velli SK, Sundaram J, Murugan M, Balaraman G, Thiruvengadam D. Protective effect of vanillic acid against benzo(a)pyrene induced lung cancer in Swiss albino mice. J Biochem Mol Toxicol. 2019;33(10):e22382.","journal-title":"J Biochem Mol Toxicol"},{"key":"3985_CR46","doi-asserted-by":"publisher","first-page":"110801","DOI":"10.1016\/j.msec.2020.110801","volume":"111","author":"K Reczynska","year":"2020","unstructured":"Reczynska K, Marchwica P, Khanal D, et al. Stimuli-sensitive fatty acid-based microparticles for the treatment of lung cancer. Mater Sci Eng C Mater Biol Appl. 2020;111:110801.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"3985_CR47","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.2147\/CMAR.S215427","volume":"11","author":"Y Cai","year":"2019","unstructured":"Cai Y, Jia R, Xiong H, et al. Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT. Cancer Manag Res. 2019;11:7391\u2013404.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"3985_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12079-020-00565-4","volume":"14","author":"A Mokhlesi","year":"2020","unstructured":"Mokhlesi A, Talkhabi M. Comprehensive transcriptomic analysis identifies novel regulators of lung adenocarcinoma. J Cell Commun Signal. 2020;14(4):453\u201365.","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"3985_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ijms21010126","volume":"21","author":"TM Khomenko","year":"2019","unstructured":"Khomenko TM, Zakharenko AL, Chepanova AA, et al. Promising new inhibitors of Tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 4-arylcoumarin and monoterpenoid moieties as components of complex antitumor therapy. Int J Mol Sci. 2019;21(1):126.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3985_CR50","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMoa0904554","volume":"361","author":"R Rosell","year":"2009","unstructured":"Rosell R, Moran T, Queralt C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361(10):958\u201367.","journal-title":"N Engl J Med"},{"issue":"21","key":"3985_CR51","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129\u201339.","journal-title":"N Engl J Med"},{"issue":"9","key":"3985_CR52","doi-asserted-by":"crossref","first-page":"e2000441","DOI":"10.1002\/cbdv.202000441","volume":"17","author":"CA Agca","year":"2020","unstructured":"Agca CA, Kirici M, Nedzvetsky VS, Gundogdu R, Tykhomyrov AA. The effect of TIGAR knockdown on apoptotic and epithelial-mesenchymal markers expression in doxorubicin-resistant non-small cell lung cancer A549 cell lines. Chem Biodivers. 2020;17(9):e2000441.","journal-title":"Chem Biodivers"},{"issue":"8","key":"3985_CR53","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1111\/1759-7714.13536","volume":"11","author":"S Manabe","year":"2020","unstructured":"Manabe S, Kasajima R, Murakami S, et al. Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique. Thoracic Cancer. 2020;11(8):2262\u20139.","journal-title":"Thoracic Cancer"},{"key":"3985_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.lungcan.2020.06.009","volume":"146","author":"W Yang","year":"2020","unstructured":"Yang W, You N, Jia M, et al. Undetectable circulating tumor DNA levels correlate with low risk of recurrence\/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer. 2020;146:327\u201334.","journal-title":"Lung Cancer"},{"issue":"9893","key":"3985_CR55","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0140-6736(13)61715-8","volume":"382","author":"R Rosell","year":"2013","unstructured":"Rosell R, Bivona TG, Karachaliou N. Genetics and biomarkers in personalisation of lung cancer treatment. Lancet. 2013;382(9893):720\u201331.","journal-title":"Lancet"},{"issue":"7","key":"3985_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11864-020-00750-y","volume":"21","author":"JA Chen","year":"2020","unstructured":"Chen JA, Riess JW. Optimal management of patients with advanced NSCLC harboring high PD-L1 expression and driver mutations. Curr Treat Options Oncol. 2020;21(7):60.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"3985_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1704795","volume":"377","author":"S Peters","year":"2017","unstructured":"Peters S, Camidge DR, Shaw AT, et al. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med. 2017;377(9):829\u201338.","journal-title":"N Engl J Med"},{"issue":"7","key":"3985_CR58","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/1871520620666200310091719","volume":"20","author":"P Verma","year":"2020","unstructured":"Verma P, Ghosh A, Ray M, Sarkar S. Lauric acid modulates cancer-associated microRNA expression and inhibits the growth of the cancer cell. Anticancer Agents Med Chem. 2020;20(7):834\u201344.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1\u20132","key":"3985_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mrfmmm.2011.11.008","volume":"733","author":"JB Kirkland","year":"2012","unstructured":"Kirkland JB. Niacin requirements for genomic stability. Mutat Res. 2012;733(1\u20132):14\u201320.","journal-title":"Mutat Res"},{"issue":"5","key":"3985_CR60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/0019-5154.190118","volume":"61","author":"MS Setia","year":"2016","unstructured":"Setia MS. Methodology series module 5: sampling strategies. Indian J Dermatol. 2016;61(5):505\u20139.","journal-title":"Indian J Dermatol"},{"issue":"5","key":"3985_CR61","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1016\/j.ygeno.2020.04.029","volume":"112","author":"C Wang","year":"2020","unstructured":"Wang C, Li S, Liu J, et al. Silencing of S-phase kinase-associated protein 2 enhances radiosensitivity of esophageal cancer cells through inhibition of PI3K\/AKT signaling pathway. Genomics. 2020;112(5):3504\u201310.","journal-title":"Genomics"},{"issue":"4","key":"3985_CR62","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S1734-1140(13)71066-1","volume":"65","author":"K Ueda","year":"2013","unstructured":"Ueda K, Nakahara T, Akanuma K, Mori A, Sakamoto K, Ishii K. Differential effects of LY294002 and wortmannin on neurons and vascular endothelial cells in the rat retina. Pharmacol Rep. 2013;65(4):854\u201362.","journal-title":"Pharmacol Rep"},{"issue":"2","key":"3985_CR63","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3892\/mmr.2016.5445","volume":"14","author":"P Yang","year":"2016","unstructured":"Yang P, Zhao J, Hou L, Yang L, Wu K, Zhang L. Vitamin E succinate induces apoptosis via the PI3K\/AKT signaling pathways in EC109 esophageal cancer cells. Mol Med Rep. 2016;14(2):1531\u20137.","journal-title":"Mol Med Rep"},{"issue":"20","key":"3985_CR64","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.3748\/wjg.v21.i20.6215","volume":"21","author":"C Li","year":"2015","unstructured":"Li C, Liu DR, Li GG, et al. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. World J Gastroenterol. 2015;21(20):6215\u201328.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03985-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T11:21:48Z","timestamp":1729423308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03985-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03985-y","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human lung cancer A549 cells were obtained from GuangZhou Jennio Biotech Co., Ltd. The ethics committee of Southern Medical University confirms that this study would have had the need for ethics approval waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}